1-(1,3-benzothiazol-2-yl)-3-N-[4-(diethylamino)phenyl]-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-(1H-indazol-5-yl)-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine;3-N-[4-(4-methylpiperazin-1-yl)phenyl]-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine

C70H79N31O2S — CID 158335782

IUPAC1-(1,3-benzothiazol-2-yl)-3-N-[4-(diethylamino)phenyl]-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-(1H-indazol-5-yl)-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine;3-N-[4-(4-methylpiperazin-1-yl)phenyl]-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine
SMILESCCN(CC)c1ccc(Nc2nc(N)n(-c3nc4ccccc4s3)n2)cc1.CN1CCN(c2ccc(Nc3nc(N)n(-c4ccccn4)n3)cc2)CC1.COc1ccc(Nc2nc(N)n(-c3nccc(N4CCCCC4)n3)n2)cc1OC.Nc1nc(Nc2ccc3[nH]ncc3c2)nn1-c1ccccn1
InChIInChI=1S/C19H24N8O2.C19H21N7S.C18H22N8.C14H12N8/c1-28-14-7-6-13(12-15(14)29-2)22-18-24-17(20)27(25-18)19-21-9-8-16(23-19)26-10-4-3-5-11-26;1-3-25(4-2)14-11-9-13(10-12-14)21-18-23-17(20)26(24-18)19-22-15-7-5-6-8-16(15)27-19;1-24-10-12-25(13-11-24)15-7-5-14(6-8-15)21-18-22-17(19)26(23-18)16-4-2-3-9-20-16;15-13-19-14(21-22(13)12-3-1-2-6-16-12)18-10-4-5-11-9(7-10)8-17-20-11/h6-9,12H,3-5,10-11H2,1-2H3,(H3,20,22,24,25);5-12H,3-4H2,1-2H3,(H3,20,21,23,24);2-9H,10-13H2,1H3,(H3,19,21,22,23);1-8H,(H,17,20)(H3,15,18,19,21)
InChIKeyGQOFHJCMRUKZCW-UHFFFAOYSA-N
MW1418.68 g/mol
LogP10.04
Rot. Bonds19

About 1-(1,3-benzothiazol-2-yl)-3-N-[4-(diethylamino)phenyl]-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-(1H-indazol-5-yl)-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine;3-N-[4-(4-methylpiperazin-1-yl)phenyl]-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine

1-(1,3-benzothiazol-2-yl)-3-N-[4-(diethylamino)phenyl]-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-(1H-indazol-5-yl)-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine;3-N-[4-(4-methylpiperazin-1-yl)phenyl]-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine (PubChem CID 158335782) has the molecular formula C70H79N31O2S and a molecular weight of 1418.68 g/mol. Its IUPAC name is 1-(1,3-benzothiazol-2-yl)-3-N-[4-(diethylamino)phenyl]-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-(1H-indazol-5-yl)-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine;3-N-[4-(4-methylpiperazin-1-yl)phenyl]-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine.

Molecular Properties

Compound Name1-(1,3-benzothiazol-2-yl)-3-N-[4-(diethylamino)phenyl]-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-(1H-indazol-5-yl)-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine;3-N-[4-(4-methylpiperazin-1-yl)phenyl]-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine
PubChem CID158335782
Molecular FormulaC70H79N31O2S
Molecular Weight1418.68 g/mol
Exact Mass1417.68
IUPAC Name1-(1,3-benzothiazol-2-yl)-3-N-[4-(diethylamino)phenyl]-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-(1H-indazol-5-yl)-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine;3-N-[4-(4-methylpiperazin-1-yl)phenyl]-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine
SMILESCCN(CC)c1ccc(Nc2nc(N)n(-c3nc4ccccc4s3)n2)cc1.CN1CCN(c2ccc(Nc3nc(N)n(-c4ccccn4)n3)cc2)CC1.COc1ccc(Nc2nc(N)n(-c3nccc(N4CCCCC4)n3)n2)cc1OC.Nc1nc(Nc2ccc3[nH]ncc3c2)nn1-c1ccccn1
InChIInChI=1S/C19H24N8O2.C19H21N7S.C18H22N8.C14H12N8/c1-28-14-7-6-13(12-15(14)29-2)22-18-24-17(20)27(25-18)19-21-9-8-16(23-19)26-10-4-3-5-11-26;1-3-25(4-2)14-11-9-13(10-12-14)21-18-23-17(20)26(24-18)19-22-15-7-5-6-8-16(15)27-19;1-24-10-12-25(13-11-24)15-7-5-14(6-8-15)21-18-22-17(19)26(23-18)16-4-2-3-9-20-16;15-13-19-14(21-22(13)12-3-1-2-6-16-12)18-10-4-5-11-9(7-10)8-17-20-11/h6-9,12H,3-5,10-11H2,1-2H3,(H3,20,22,24,25);5-12H,3-4H2,1-2H3,(H3,20,21,23,24);2-9H,10-13H2,1H3,(H3,19,21,22,23);1-8H,(H,17,20)(H3,15,18,19,21)
InChIKeyGQOFHJCMRUKZCW-UHFFFAOYSA-N
XLogP10.04
TPSA399.59 Ų
H-Bond Donors9
H-Bond Acceptors33
Rotatable Bonds19
Heavy Atoms104
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001418.68
LogP ≤ 510.04
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1033

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_A(478)', 'substructure': 'N/A'}

Analyze 1-(1,3-benzothiazol-2-yl)-3-N-[4-(diethylamino)phenyl]-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-(1H-indazol-5-yl)-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine;3-N-[4-(4-methylpiperazin-1-yl)phenyl]-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-(1,3-benzothiazol-2-yl)-3-N-[4-(diethylamino)phenyl]-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-(1H-indazol-5-yl)-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine;3-N-[4-(4-methylpiperazin-1-yl)phenyl]-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine?
The IUPAC name of 1-(1,3-benzothiazol-2-yl)-3-N-[4-(diethylamino)phenyl]-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-(1H-indazol-5-yl)-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine;3-N-[4-(4-methylpiperazin-1-yl)phenyl]-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine (CID 158335782) is 1-(1,3-benzothiazol-2-yl)-3-N-[4-(diethylamino)phenyl]-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-(1H-indazol-5-yl)-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine;3-N-[4-(4-methylpiperazin-1-yl)phenyl]-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine.
What is the SMILES notation for 1-(1,3-benzothiazol-2-yl)-3-N-[4-(diethylamino)phenyl]-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-(1H-indazol-5-yl)-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine;3-N-[4-(4-methylpiperazin-1-yl)phenyl]-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine?
The canonical SMILES for 1-(1,3-benzothiazol-2-yl)-3-N-[4-(diethylamino)phenyl]-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-(1H-indazol-5-yl)-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine;3-N-[4-(4-methylpiperazin-1-yl)phenyl]-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine is CCN(CC)c1ccc(Nc2nc(N)n(-c3nc4ccccc4s3)n2)cc1.CN1CCN(c2ccc(Nc3nc(N)n(-c4ccccn4)n3)cc2)CC1.COc1ccc(Nc2nc(N)n(-c3nccc(N4CCCCC4)n3)n2)cc1OC.Nc1nc(Nc2ccc3[nH]ncc3c2)nn1-c1ccccn1.
What is the InChIKey of 1-(1,3-benzothiazol-2-yl)-3-N-[4-(diethylamino)phenyl]-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-(1H-indazol-5-yl)-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine;3-N-[4-(4-methylpiperazin-1-yl)phenyl]-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine?
The InChIKey is GQOFHJCMRUKZCW-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H24N8O2.C19H21N7S.C18H22N8.C14H12N8/c1-28-14-7-6-13(12-15(14)29-2)22-18-24-17(20)27(25-18)19-21-9-8-16(23-19)26-10-4-3-5-11-26;1-3-25(4-2)14-11-9-13(10-12-14)21-18-23-17(20)26(24-18)19-22-15-7-5-6-8-16(15)27-19;1-24-10-12-25(13-11-24)15-7-5-14(6-8-15)21-18-22-17(19)26(23-18)16-4-2-3-9-20-16;15-13-19-14(21-22(13)12-3-1-2-6-16-12)18-10-4-5-11-9(7-10)8-17-20-11/h6-9,12H,3-5,10-11H2,1-2H3,(H3,20,22,24,25);5-12H,3-4H2,1-2H3,(H3,20,21,23,24);2-9H,10-13H2,1H3,(H3,19,21,22,23);1-8H,(H,17,20)(H3,15,18,19,21).
What are the key properties of 1-(1,3-benzothiazol-2-yl)-3-N-[4-(diethylamino)phenyl]-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-(1H-indazol-5-yl)-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine;3-N-[4-(4-methylpiperazin-1-yl)phenyl]-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine?
1-(1,3-benzothiazol-2-yl)-3-N-[4-(diethylamino)phenyl]-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-(1H-indazol-5-yl)-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine;3-N-[4-(4-methylpiperazin-1-yl)phenyl]-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine has a molecular weight of 1418.68 g/mol, XLogP of 10.04, 19 rotatable bonds, 9 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(1,3-benzothiazol-2-yl)-3-N-[4-(diethylamino)phenyl]-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-(1H-indazol-5-yl)-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine;3-N-[4-(4-methylpiperazin-1-yl)phenyl]-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine is sourced from PubChem (CID 158335782), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).